Erika is a leader in digital and analytics R&D within our Life Sciences Practice. She serves biopharmaceutical companies on various topics, including diagnostics, personalized healthcare, AI, machine learning strategy and implementation for use cases, broader business strategy, and R&D and medical-affairs approaches.
Some of her recent work includes the following:
- implementing a digital transformation for the research organization of a biotechnology company, including implementation of machine vision and AI
- designing and building best-in-class tools for clinical trial planning
- conducting advanced-analytics-driven real world data use cases to inform understanding of treatment landscapes and physician treatment patterns
- defining the strategy, use, and business case for an ambitious patient-level data collection effort for a pharmaceutical company
- supporting R&D strategies, such as portfolio and organization, for both large pharmaceutical and midsize biotech companies
- conducting diligence and technology evaluations on a variety of different assets in the life-sciences space
Prior to joining McKinsey, Erika founded an oncology biotech company focused on RAS-pathway inhibitors. In her spare time, Erika likes to read mystery novels and go skiing in the Alps with her family.